Cellectis Pink Sheet Forward View - Accumulation Distribution
| CMVLF Stock | USD 4.40 0.00 0.00% |
This reference view applies Accumulation Distribution to Cellectis SA's historical closing prices. Cellectis SA's Accumulation Distribution reference page summarizes the forecasted price and model accuracy metrics from daily trading data. Cellectis SA's forecast reference data is generated from the equity's historical trading prices. Mean absolute deviation and related metrics help quantify forecast uncertainty for Cellectis SA.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume All forecast values on this page for Cellectis SA are Accumulation Distribution reference data derived from historical price series. Accumulation Distribution Analysis Today
Cellectis SA has current Accumulation Distribution of 0. The accumulation distribution (A/D) indicator shows the degree to which Cellectis is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Cellectis SA to determine if accumulation or reduction is taking place in the market. This value is adjusted by Cellectis trading volume to give more weight to distributions with higher volume over lower volume.| Volatility | Backtest | Information Ratio |
Cellectis Trading Date Momentum
| On March 25 2026 Cellectis SA was traded for 4.40 at the closing time. The highest daily price throughout the period was 4.40 and the lowest price was 4.40 . There was no trading activity during the period. Lack of trading volume on 03/25/2026 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Cellectis to competition |
Other Forecasting Options for Cellectis
Volume-weighted price analysis for Cellectis Pink Sheet gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line can identify shifts in Cellectis momentum before they appear in raw price. Comparing Cellectis' realized volatility to implied volatility reveals whether the options market expects larger or smaller moves. Readings above 80 or below 20 highlight potential reversal zones in Cellectis Pink Sheet price action.Cellectis Related Equities
Sizing up Cellectis against these stocks within the Biotechnology space shows how it compares on key financial measures. Profit comparisons show whether Cellectis earns above or below average returns next to its peers. Sector-wide trends across this peer group can help split company-level factors from broader forces. Tracking Cellectis' results against these peers over time helps spot rising trends early.
| Risk & Return | Correlation |
Cellectis Market Strength Events
Evaluating the market strength of Cellectis pink sheet allows investors to gauge shifts in market momentum. Monitoring these indicators highlights periods where Cellectis SA trading conditions shift meaningfully. These metrics are particularly useful when Cellectis pink sheet shows divergence from broader market trends. Regularly reviewing Cellectis SA strength signals helps maintain a structured approach to position management.
Cellectis Risk Indicators
Understanding Cellectis' risk indicators is essential for any investor seeking to forecast its future price accurately. By identifying how much risk is embedded in Cellectis' investment, investors can decide how to position their exposure. Reviewing Cellectis' basic risk indicators is essential for managing investment risk effectively. The risk-return trade-off for cellectis pink sheet becomes clearer when Cellectis' risk indicators are properly assessed.
| Mean Deviation | 0.0728 | |||
| Standard Deviation | 0.2869 | |||
| Variance | 0.0823 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cellectis
A coverage review of Cellectis SA shows when the security is attracting above-average attention from contributors and market observers. The practical risk is that faster visibility can increase both interest and skepticism at the same time.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
More Resources for Cellectis Pink Sheet Analysis
Additional Information and Resources on Investing in Cellectis Pink Sheet
The foundation for reviewing Cellectis SA is its financial reporting and trend data. The dataset reflects Cellectis' financial reporting across available periods.The Historical Fundamental Analysis of Cellectis module adds a historical reference layer for Cellectis' projections.Cellectis currently shows ROE of -55.7%, market cap of 131.39 Million. This analysis of Cellectis works best as a complementary layer when evaluating how the security fits in a broader portfolio. Within the Healthcare space, Cellectis peer comparison and risk tools below help frame relative strengths and weaknesses. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.